3 April 2025 The pressures of IP law can take a serious toll on mental wellbeing. Boult Wade Tennant partner and WIPR ...

Why CIPA sees ‘a golden opportunity’ ...

20 February 2025 Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key ...

The hire brings experience managing global trademark, copyright, and domain portfolios, as well as prior in-house roles at ...

A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their IP strategies.

The pharma giant will share rights to new innovations with an AI-driven organoid platform designed to produce fully human ...

16 September 2025 From drug discovery to post-market surveillance, AI is rewriting the rules in pharma—and the patent system ...

26 September 2025 Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and ...

As a US federal shutdown grips IP-critical agencies, layoffs, office closures, and resource cutbacks are underway at the US ...

A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party ...

The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for ...

As John Squires makes the bold move to allow patentability of an AI-related invention in Ex parte Desjardins, patent experts ...